Skip to content

Clinical trials

Phase 3 Diabetic Retinopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Phase 3 Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20041
20054
20064
20074
20082
20093
20101
20113
20121
20131
20162
20186
20192
20203
20213
20221
20242
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated9
Unknown status6
Withdrawn2
Recruiting2
Not yet recruiting2
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jaeb Center for Health Research6
National Eye Institute (NEI)6
Novartis Pharmaceuticals6
Kodiak Sciences Inc4
Chromaderm, Inc.3
Asociación para Evitar la Ceguera en México2
Bausch & Lomb Incorporated2
Merck Sharp & Dohme LLC2
Novartis2
Ollin Biosciences, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy59
Macular Edema14
Diabetes Mellitus9
Retinal Diseases8
Vision Disorders7
Eye Diseases5
Retinal Degeneration5
Vitreous Hemorrhage4
Blindness2
Diabetes Mellitus, Type 12

Trials

Showing 76 to 59 of 59. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.